Zerbini LF
Zerbini LF
Zerbini LF is Group Leader of Cancer Genomics Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), South Africa
Biography
Education
University of Sao Paulo (USP),Molecular Virology, São Paulo, Brazil, PhD, 1999
Federal University of Sao Paulo, Paulista Medicine School, São Paulo, Brazil, Master in Science, 1993
Campinas State University (UNICAMP), Campinas, Brazil, BSc in Biomedical Sciences, 1989
Career History
Since 2009, Group Leader Cancer Genomics Group, International Centre for Genetic engineer and Biotechnology, Cape Town, South Africa
2004-2009, Faculty Instructor in Medicine, Harvard Medical School, Boston, USA
2004-2009, Associate Director, Research Proteomics, BIDMC Genomics Center and DFHC Proteomics Core, Boston, USA
2003-2004, Senior Research Scientist, BIDMC Genomics Center, Harvard Medical School, Boston, USA
1999-2003, Postdoctoral Fellow, BIDMC Genomics Center, Harvard Medical School, Boston, USA
1994-1995, Assistant Professor, Department of Microbiology, Paulista Medicine School, São Paulo, Brazil
Research Interest
The overall goals of the laboratory are to utilize genomics and proteomics tools and signal transduction resources to accelerate comparative analysis of aberrant gene expression in carcinogenesis and to study alterations in signal transduction pathways during development of cancers. Areas of research include: regulation of gene expression by transcription factors, the role of receptor tyrosine kinases in cancer malignancies, aberrant gene expression in carcinogenesis and alterations in signal transduction pathways and gene translocations.